- Latest news▼
-
15:11, April 24 Zombie deer disease possibly linked to hunters’ deaths
-
12:27, April 23 Appetite: Scientists found out the secret to the appeal of large portions of fast food
-
10:33, April 23 Scientists test new approach to fighting viruses
-
08:38, April 23 Ketamine may help with postpartum depression
-
22:12, April 22 Unhealthy amount of sugar found in baby food products of a well-known brand
-
19:41, April 22 Air pollution puts health of more than 1.6 billion workers globally at risk
-
17:25, April 22 Scientists found baked goods and lack of sleep to be more dangerous than alcohol
-
16:02, April 22 342 cases of measles recorded in Armenia so far in 2024
-
15:29, April 22 BrainStimulation: electrical brain stimulation alleviates anxiety and depression in the elderly
-
08:27, April 22 Cognitively stimulating jobs in midlife could lower dementia risk in old age, study finds
-
20:37, April 21 Environmental Health Perspectives: Microplastics ingested with food and water can spread from the gut to the brain
-
22:41, April 20 Scientists develop new method to safely stimulate immune cells to fight cancer
-
20:46, April 20 Blood test can determine who is at risk of developing multiple sclerosis - scientists
-
18:36, April 20 Next pandemic likely to be triggered by flu - scientists
-
12:16, April 19 Scientists grow human mini-lungs in lab
All materials
China sends experimental Ebola drug to Africa
A Chinese drugmaker with military ties has sent an experimental Ebola drug to Africa for use by Chinese aid workers and is planning clinical trials there to combat a deadly outbreak of the disease, executives at the firm told Reuters on Thursday.
Sihuan Pharmaceutical Holdings Group Ltd has supplied several thousand doses of its drug JK-05 to the region, Chief Operating Officer Jia Zhongxin said. More doses could be sent if needed, Jia said.
"Aid workers have already taken the drug with them, and if a case breaks out (amongst the aid workers), then the drug may be used," added Huo Caixia, Sihuan's assistant general manager.
Sihuan, part-owned by U.S. investment bank Morgan Stanley , is hoping to get the drug fast-tracked for civilian use in China. It has signed an agreement with the Academy of Military Medical Sciences (AMMS), a research unit, to seek approval for the drug's use in China and push it to market.
Follow NEWS.am Medicine on Facebook and Twitter
- Video
- Event calendar
- Archive
- Most read
month
week
day
- JAMA Oncology: Urine test can help rule out high-grade prostate cancer with almost 100% accuracy, study shows 1252
- Daily Mail: Elderly woman in China gets infected with brain-eating amoeba 1193
- Obesity: exercising before breakfast helps you lose weight faster 1173
- Scientists grow human mini-lungs in lab 1142
- Next pandemic likely to be triggered by flu - scientists 872
- Scientists found baked goods and lack of sleep to be more dangerous than alcohol 784
- 342 cases of measles recorded in Armenia so far in 2024 743
- Blood test can determine who is at risk of developing multiple sclerosis - scientists 725
- Scientists develop new method to safely stimulate immune cells to fight cancer 723
- Cognitively stimulating jobs in midlife could lower dementia risk in old age, study finds 707
- BrainStimulation: electrical brain stimulation alleviates anxiety and depression in the elderly 654
- Air pollution puts health of more than 1.6 billion workers globally at risk 521
- Unhealthy amount of sugar found in baby food products of a well-known brand 513
- Ketamine may help with postpartum depression 500
- Appetite: Scientists found out the secret to the appeal of large portions of fast food 499
- Find us on Facebook
- Poll